{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:54:24Z","timestamp":1767833664535,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,4]]},"DOI":"10.7759\/cureus.59641","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T15:52:46Z","timestamp":1714837966000},"source":"Crossref","is-referenced-by-count":1,"title":["Navigating Treatment Challenges: A Case Study on Refractory Psychosis in a Chronic MDMA (3,4-Methylenedioxymethamphetamine) User"],"prefix":"10.7759","author":[{"given":"Melissa N","family":"Litenski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoife B","family":"O'Reardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Pabon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakov","family":"Niyazov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre R","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M, Roset PN, et al.. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004, 26:137-44. 10.1097\/00007691-200404000-00009","journal-title":"Ther Drug Monit"},{"key":"ref2","unstructured":"NIDA-What is the scope of MDMA use in the United States?. (2024). Accessed. December 12, 2023: https:\/\/nida.nih.gov\/publications\/research-reports\/mdma-ecstasy-abuse\/what-is-the-scope-of-mdma-use-in-the-united-states."},{"key":"ref3","article-title":"Substance-related disorders","author":"Kaplan HI","year":"2007","unstructured":"Kaplan HI, Sadock BJ. Substance-related disorders. Kaplan & Sadock's Synopsis of Psychiatry. Tenth Edition. Cambridge University Press, Philadelphia, PA; 2007. 381-466."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-5846(97)00045-6","article-title":"Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: \"Ecstasy\")","volume":"21","author":"Cohen RS","year":"1997","unstructured":"Cohen RS, Cocores J. Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: \"Ecstasy\"). Prog Neuropsychopharmacol Biol Psychiatry. 1997, 21:727-34. 10.1016\/s0278-5846(97)00045-6","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.11l01200","article-title":"Persistent psychosis after a single ingestion of \"Ecstasy\" (MDMA)","volume":"13","author":"Patel A","year":"2011","unstructured":"Patel A, Moreland T, Haq F, Siddiqui F, Mikul M, Qadir H, Raza S. Persistent psychosis after a single ingestion of \"Ecstasy\" (MDMA). Prim Care Companion CNS Disord. 2011, 13:PCC.11l01200. 10.4088\/PCC.11l01200","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3058","article-title":"Persistent psychosis due to single dose of ecstasy","volume":"10","author":"Virani S","year":"2018","unstructured":"Virani S, Daya GN, Brainch N, Kotapati VP, Zaveri D, Ahmed S. Persistent psychosis due to single dose of ecstasy. Cureus. 2018, 10:e3058. 10.7759\/cureus.3058","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/add.14708","article-title":"Psychostimulant use and the brain","volume":"114","author":"Lappin JM","year":"2019","unstructured":"Lappin JM, Sara GE. Psychostimulant use and the brain. Addiction. 2019, 114:2065-77. 10.1111\/add.14708","journal-title":"Addiction"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.32598\/bcn.9.10.485","article-title":"MDMA and the brain: a short review on the role of neurotransmitters in neurotoxicity","volume":"11","author":"Mustafa NS","year":"2020","unstructured":"Mustafa NS, Bakar NH, Mohamad N, et al.. MDMA and the brain: a short review on the role of neurotransmitters in neurotoxicity. Basic Clin Neurosci. 2020, 11:381-8. 10.32598\/bcn.9.10.485","journal-title":"Basic Clin Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyad023","article-title":"Chronic 3,4-methylenedioxymethamphetamine (MDMA) use is related to glutamate and GABA concentrations in the striatum but not the anterior cingulate cortex","volume":"26","author":"Zimmermann J","year":"2023","unstructured":"Zimmermann J, Z\u00f6lch N, Coray R, et al.. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use is related to glutamate and GABA concentrations in the striatum but not the anterior cingulate cortex. Int J Neuropsychopharmacol. 2023, 26:438-50. 10.1093\/ijnp\/pyad023","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13977","article-title":"The neurobiology of impulsivity and substance use disorders: implications for treatment","volume":"1451","author":"Kozak K","year":"2019","unstructured":"Kozak K, Lucatch AM, Lowe DJ, Balodis IM, MacKillop J, George TP. The neurobiology of impulsivity and substance use disorders: implications for treatment. Ann N Y Acad Sci. 2019, 1451:71-91. 10.1111\/nyas.13977","journal-title":"Ann N Y Acad Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.06.005","article-title":"Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes","volume":"34","author":"Tost H","year":"2010","unstructured":"Tost H, Alam T, Meyer-Lindenberg A. Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev. 2010, 34:689-700. 10.1016\/j.neubiorev.2009.06.005","journal-title":"Neurosci Biobehav Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.42.6.525","article-title":"Persistent psychosis after a single ingestion of 'ecstasy'","volume":"42","author":"Van Kampen J","year":"2001","unstructured":"Van Kampen J, Katz M. Persistent psychosis after a single ingestion of 'ecstasy'. Psychosomatics. 2001, 42:525-7. 10.1176\/appi.psy.42.6.525","journal-title":"Psychosomatics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers JP","year":"2023","unstructured":"Rogers JP, Oldham MA, Fricchione G, et al.. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023, 37:327-69. 10.1177\/02698811231158232","journal-title":"J Psychopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.07.109","article-title":"The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials","volume":"276","author":"Fornaro M","year":"2020","unstructured":"Fornaro M, Carvalho AF, Fusco A, et al.. The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials. J Affect Disord. 2020, 276:970-83. 10.1016\/j.jad.2020.07.109","journal-title":"J Affect Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/243382-navigating-treatment-challenges-a-case-study-on-refractory-psychosis-in-a-chronic-mdma-34-methylenedioxymethamphetamine-user","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T15:52:50Z","timestamp":1714837970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/243382-navigating-treatment-challenges-a-case-study-on-refractory-psychosis-in-a-chronic-mdma-34-methylenedioxymethamphetamine-user"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.59641","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,4]]}}}